OTC: SHPMF - Shanghai Pharmaceuticals Holding Co., Ltd

Yield per half year: -6.47%
Dividend yield: +4.36%
Sector: Healthcare

Share chart Shanghai Pharmaceuticals Holding Co., Ltd

Extended chart Simple chart
Financial Markets by TradingView

About Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs.

more details
The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores, and online drug business. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Health Care Providers & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 4.12
Дивиденд ао 0.0676
Сайт https://www.sphchina.com
Цена ао 1.56
Change price per day: +0% (1.562)
Change price per week: +0% (1.562)
Change price per month: +31.26% (1.19)
Change price per 3 month: -4.76% (1.64)
Change price per half year: -6.47% (1.67)
Change price per year: +5.19% (1.485)
Change price per 3 year: -10.74% (1.75)
Change price per year to date: -4.76% (1.64)
All parameters

Underestimation

Title Value Grade
P/S 0.1331 10
P/BV 0.0607 10
P/E 9.19 9
EV/EBITDA 12.31 7
Total: 7.38

Efficiency

Title Value Grade
ROA, % 0.2504 1
ROE, % 0.7745 1
Total: 0.8333

Dividends

Title Value Grade
Div yield, % 4.36 10
DSI 0.7143 7.14
Total: 6.9

Debt

Title Value Grade
Debt/EBITDA 26.99 0
Total: 3.2

Growth impulse

Title Value Grade
Yield Revenue, % -80.29 0
Yield Ebitda, % -83.84 0
Yield EPS, % -90.01 0
Total: 0
More

More

Institutions Volume Share, %
Vanguard International Stock Index-Emerging Markets Stk 12146926 1.32
Vanguard International Stock Index-Total Intl Stock Indx 11883576 1.29
iShares Core MSCI Emerging Markets ETF 7102300 0.77
Brandes Emerging Markets Value Fund 5203000 0.57
DFA Emerging Markets Core Equity Portfolio 4172100 0.45
iShares MSCI Emerging Markets Minimum Volatility Factor ETF 3566400 0.39
DFA Investment Dimensions-DFA Emerging Mkts Value 3299900 0.36
iShares ESG Aware MSCI EM ETF 3014100 0.33
iShares MSCI China ETF 2093800 0.23
iShares MSCI Emerging Markets ETF 1923800 0.21



Head Job title Payment Year of birth
Mr. Bo Shen President, CFO, Head of the Accounting Department & Executive Director 804.26k 1973 (52 years)
Mr. Yongzhong Li VP & Executive Director 904.39k 1970 (55 years)
Mr. Tao Zhong VP, Board Secretary & Joint Company Secretary N/A 1972 (53 years)
Mr. Dongming Li Vice President N/A 1969 (56 years)
Ms. Shuai Shao Vice President N/A 1988 (37 years)
Dr. Shunjiang Yu Chief Medical Officer N/A
Mr. Ming Dong Executive Director N/A 1976 (49 years)
Ying Ke Director & General Manager of R&D Management Center N/A
Mr. Qiuhua Yang Executive Chairman N/A 1972 (53 years)
Ms. Pui Kiu Wong Joint Company Secretary N/A

Address: China, Shanghai, Shanghai Pharmaceutical Building - open in Google maps, open in Yandex maps
Website: https://www.sphchina.com